跳至主要内容
临床试验/ACTRN12607000321448
ACTRN12607000321448招募中3 期

A randomised, placebo controlled trial of Vitamin D in older adults with mild cognitive impairment and low vitamin D concentration to prevent cognitive decline and delay progression of cognitive decline.

Professor Nicola Lautenschlager0 个研究点目标入组 110 人开始时间: 2007年6月18日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 ot stated(—)
性别
All

入选标准

  • Adults with mild cognitive impairment (-1.5 standard deviations below norm on any task in the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological battery), over 65 years of age, Vitamin D concentration between 12.5 and 50 nmol/L at baseline.

排除标准

  • Diagnosis of osteoporosis requiring treatment, no informant available, severe physical or medical illness that would preclude completion of the trial, hearing or visual impairment that would preclude assessments, already in an intervention trial, clinical history of stroke, fall in the last 3 months, heart attack in the last 3 months, fall with fracture over the age of 65, history of kidney or bladder stones, current acute depression, history of schizophrenia, current diagnosis of dementia.

研究者

发起方
Professor Nicola Lautenschlager

相似试验